Suchergebnisse - "Ndjeka, Norbert"

“I would watch her with awe as she swallowed the first handful”: A qualitative study of pediatric multidrug-resistant tuberculosis experiences in Durban, South Africa von Misra, Shriya, Misra, Nirupa, Seepamore, Boitumelo, Holloway, Kerry, Singh, Nalini, Ngozo, Jacqui, Dlamini, Vusi, Radebe, Zanele, Ndjeka, Norbert O., Furin, Jennifer

“… Background There are limited data on the experiences of children being treated for drug-resistant tuberculosis (DR-TB), and most work in the area has been done …”
Volltext

Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF von Churchyard, Gavin J, Stevens, Wendy S, Mametja, Lerole D, McCarthy, Kerrigan M, Chihota, Violet, Nicol, Mark P, Erasmus, Linda K, Ndjeka, Norbert O, Mvusi, Lindiwe, Vassall, Anna, Sinanovic, Edina, Cox, Helen S, Dye, Christopher, Grant, Alison D, Fielding, Katherine L

“… In South Africa, sputum smear microscopy has been replaced with Xpert MTB/RIF as the initial diagnostic test for tuberculosis. In a pragmatic parallel …”
Volltext

A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants von Jassat, Waasila, Mudara, Caroline, Vika, Caroline, Welch, Richard, Arendse, Tracy, Dryden, Murray, Blumberg, Lucille, Mayet, Natalie, Tempia, Stefano, Parker, Arifa, Nel, Jeremy, Perumal, Rubeshan, Groome, Michelle J., Conradie, Francesca, Ndjeka, Norbert, Sigfrid, Louise, Merson, Laura, Cohen, Cheryl

“… •A total of 47% of hospitalized and 19% of nonhospitalized participants had symptoms at 6 months.•There was no difference in persistent symptoms by HIV …”
Volltext

The effectiveness, cost-effectiveness, budget impact, and return on investment of scaling up tuberculosis screening and preventive treatment in Brazil, Georgia, Kenya, and South Africa: a modelling study von Vesga, Juan F, PhD, Mohamed, Mona Salaheldin, PhD, Shandal, Monica, MSc, Jabbour, Elias, MSc, Lomtadze, Nino, MD, Kubjane, Mmamapudi, PhD, Trajman, Anete, Prof, Meyer-Rath, Gesine, Prof, Avaliani, Zaza, PhD, Rotich, Wesley, MSc, Mwai, Daniel, PhD, Croda, Julio, MD, Mathema, Hlengani T, MPH, Kathure, Immaculate, MD, Pola, Rhoda, MSc, Costa, Fernanda Dockhorn, MD, Ndjeka, Norbert O, MMed, Danelia, Maka, PhD, Tonini, Maiko L, PhD, Solomonia, Nelly, PhD, Pelissari, Daniele M, PhD, Falzon, Dennis, MD, Miller, Cecily, PhD, Baena, Ines Garcia, MSc, Arinaminpathy, Nimalan, PhD, Schwartzman, Kevin, Prof, Den Boon, Saskia, PhD, Campbell, Jonathon R, PhD

“… SummaryBackgroundClosing the tuberculosis diagnostic gap and scaling up tuberculosis preventive treatment (TPT) are two global priorities to end tuberculosis …”
Volltext

Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study von Cox, Helen, Dickson-Hall, Lindy, Ndjeka, Norbert, van’t Hoog, Anja, Grant, Alison, Cobelens, Frank, Stevens, Wendy, Nicol, Mark

“… South Africa has a large burden of rifampicin-resistant tuberculosis (RR-TB), with 18,734 patients diagnosed in 2014. The number of diagnosed patients has …”
Volltext

Tuberculosis testing patterns in South Africa to identify groups that would benefit from increased investigation von Shapiro, Anne N., Scott, Lesley, Moultrie, Harry, Jacobson, Karen R., Bor, Jacob, Fofana, Abdou M., Dor, Graeme, Ndjeka, Norbert O., da Silva, Pedro, Mlisana, Koleka, Jenkins, Helen E., Stevens, Wendy S.

“… The National Health Laboratory Service (NHLS) collects all public health laboratory test results in South Africa, providing a cohort from which to identify …”
Volltext

Successful Multidrug-Resistant Tuberculosis Treatment Without HIV Viral Suppression: A Missed Opportunity von Geiger, Keri, Patil, Amita, Budhathoki, Chakra, Dooley, Kelly E, Lowensen, Kelly, Ndjeka, Norbert, Ngozo, Jacqueline, Farley, Jason E

“… Coinfection with multidrug-resistant tuberculosis (MDR-TB) and HIV is common, but few published studies examine how undergoing MDR-TB treatment affects HIV …”
Weitere Angaben

Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis von Pai, Helen, Ndjeka, Norbert, Mbuagbaw, Lawrence, Kaniga, Koné, Birmingham, Eileen, Mao, Gary, Alquier, Lori, Davis, Kourtney, Bodard, Arianne, Williams, Abeda, Van Tongel, Magalie, Thoret-Bauchet, Florence, Omar, Shaheed V., Bakare, Nyasha

“… Background This retrospective cohort study assessed benefits and risks of bedaquiline treatment in multidrug-resistant-tuberculosis (MDR-TB) combination …”
Volltext

Global adoption of 6-month drug-resistant TB regimens: Projected uptake by 2026 von Gupta, Aastha, Juneja, Sandeep, Babawale, Victor, Rustam Majidovich, Nurov, Ndjeka, Norbert, Thi Mai Nguyen, Phuong, Nargiza Nusratovna, Parpieva, Robert Omanito, David, Tiara Pakasi, Tiffany, Terleeva, Yana, Toktogonova, Atyrkul, Waheed, Yasir, Myint, Zaw, Yanlin, Zhao, Sahu, Suvanand

“… The WHO has issued a call to action urging countries to accelerate the rollout of new WHO-recommended shorter all-oral treatment regimens for drug-resistant TB …”
Volltext

The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis von Dheda, Keertan, Gumbo, Tawanda, Maartens, Gary, Dooley, Kelly E, Murray, Megan, Furin, Jennifer, Nardell, Edward A, Warren, Robin M

“… The Lancet Respiratory Medicine Commission on drug-resistant tuberculosis was published in 2017, which comprehensively reviewed and provided recommendations on …”
Weitere Angaben

Defining Bedaquiline Susceptibility, Resistance, Cross-Resistance and Associated Genetic Determinants: A Retrospective Cohort Study von Ismail, Nazir A., Omar, Shaheed V., Joseph, Lavania, Govender, Netricia, Blows, Linsay, Ismail, Farzana, Koornhof, Hendrik, Dreyer, Andries W., Kaniga, Koné, Ndjeka, Norbert

“… Bedaquiline (BDQ) is a novel agent approved for use in combination treatment of multi-drug resistant tuberculosis (MDR-TB). We sought to determine BDQ …”
Volltext

Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines von Gomez, Gabriela Beatriz, Siapka, Mariana, Conradie, Francesca, Ndjeka, Norbert, Garfin, Anna Marie Celina, Lomtadze, Nino, Avaliani, Zaza, Kiria, Nana, Malhotra, Shelly, Cook-Scalise, Sarah, Juneja, Sandeep, Everitt, Daniel, Spigelman, Melvin, Vassall, Anna

“… ObjectivesPatients with highly resistant tuberculosis have few treatment options. Bedaquiline, pretomanid and linezolid regimen (BPaL) is a new regimen shown …”
Volltext

Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis von Campbell, Jonathon R., Falzon, Dennis, Mirzayev, Fuad, Jaramillo, Ernesto, Migliori, Giovanni Battista, Mitnick, Carole D., Ndjeka, Norbert, Menzies, Dick

“… International policy for treatment of multidrug- and rifampin-resistant tuberculosis (MDR/RR TB) relies largely on individual patient data (IPD) from …”
Volltext

Advances in clinical trial design for development of new TB treatments—Translating international tuberculosis treatment guidelines into national strategic plans: Experiences from Belarus, South Africa, and Vietnam von Brigden, Grania, Nhung, Nguyen Viet, Skrahina, Alena, Ndjeka, Norbert, Falzon, Dennis, Zignol, Matteo

“… About the Authors: Grania Brigden * E-mail: grania.brigden@theunion.org Affiliation: Department of Tuberculosis, The International Union Against TB and Lung …”
Volltext

Organisation of care for people receiving drug-resistant tuberculosis treatment in South Africa: a mixed methods study von Dickson, Lindy, Le Roux, Sacha Roxanne, Mitrani, Leila, Hill, Jeremy, Jassat, Waasila, Cox, Helen, Mlisana, Koleka, Black, John, Loveday, Marian, Grant, Alison, Kielmann, Karina, Ndjeka, Norbert, Moshabela, Mosa, Nicol, Mark

“… ObjectivesTreatment for multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) is increasingly transitioning from hospital-centred to …”
Volltext

Predictors of mortality and treatment success during treatment for rifampicin-resistant tuberculosis within the South African National TB Programme, 2009 to 2011: a cohort analysis of the national case register von Schnippel, Kathryn, Shearer, Kate, Evans, Denise, Berhanu, Rebecca, Dlamini, S’celo, Ndjeka, Norbert

“… •We reviewed 17697 cases of rifampicin-resistant TB treated in South Africa from 2009 to 2011.•We examined associations between patient characteristics and …”
Volltext

Climate change and tuberculosis: an analytical framework von Saunders, Matthew J, Boccia, Delia, Khan, Palwasha Y, Goscé, Lara, Gasparrini, Antonio, Clark, Rebecca A, Pescarini, Julia M, Charalambous, Salome, Fekadu, Lelisa, Dockhorn da Costa Johansen, Fernanda, Vasilyeva, Irina, Narendran, Gopalan, Li, Tao, Ndjeka, Norbert, White, Richard G, Houben, Rein M G J, Zignol, Matteo, Gebreselassie, Nebiat, McQuaid, Christopher Finn

“… Climate change is likely to exacerbate a range of determinants that drive tuberculosis, the world's leading cause of death from a single infectious agent …”
Weitere Angaben

Pre-treatment loss to follow-up among children with multidrug-resistant tuberculosis in South Africa, 2008–2010 von Moore, Brittany K., Erasmus, Linda, Ershova, Julia, Smith, Sarah E., Ndjeka, Norbert, Podewils, Laura J.

“… Multidrug-resistant (MDR) TB is more difficult to diagnose and treat compared with drug-susceptible TB. Young children are at greater risk of severe TB disease …”
Volltext

Bedaquiline and clofazimine: successes and challenges von Ndjeka, Norbert, Ismail, Nazir A

Volltext

Evaluation of a nurse practitioner-physician task-sharing model for multidrug-resistant tuberculosis in South Africa von Farley, Jason E., Ndjeka, Norbert, Kelly, Ana M., Whitehouse, Erin, Lachman, Simmi, Budhathoki, Chakra, Lowensen, Kelly, Bergren, Ellie, Mabuza, Hloniphile, Mlandu, Ntombasekhaya, van der Walt, Martie

“… Treatment success rates for multidrug-resistant tuberculosis (MDR-TB) in South Africa remain close to 50%. Lack of access to timely, decentralized care is a …”
Volltext